Clinical Trial Opportunity for Triple-Negative Breast Cancer
| Date | Form | Description | XBRL | Pages |
|---|---|---|---|---|
| 05/31/24 | UPLOAD | Form UPLOAD: SEC-generated letter | 1 | |
| 05/24/24 | S-3 | Form S-3: Registration statement for specified transactions by certain issuers | 77 | |
| 05/16/24 | DEFR14A | Form DEFR14A: Definitive revised proxy soliciting materials | 2 | |
| 05/14/24 | 8-K | Form 8-K: Current report filing |
|
5 |
| 05/14/24 | 10-Q | Form 10-Q: Quarterly report pursuant to Section 13 or 15(d) |
|
36 |
| 04/26/24 | ARS | Form ARS: Annual report to security holders | 85 | |
| 04/26/24 | DEFA14A | Form DEFA14A: Additional definitive proxy soliciting materials and Rule 14(a)(12) material | 3 | |
| 04/26/24 | DEF 14A | Form DEF 14A: Definitive proxy statements | 32 | |
| 04/25/24 | SC 13G/A | Form SC 13G/A: Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions | 11 | |
| 04/01/24 | 10-K/A | Form 10-K/A: Annual report pursuant to Section 13 and 15(d) |
|
11 |